1. Department of Pathology and Experimental Therapeutics, Medical School, University of Barcelona, Barcelona, Spain;
2. Ciber-BBN (Nanomol), Department of Molecular Nanoscience and Organic Materials, Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Cerdanyola del Vallès, Spain;
3. Ciber-BBN (NanoBioCel), Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria, Spain